학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 23건 | 목록
1~20
Academic Journal
Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van Berge Henegouwen JM; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; van der Wijngaart H; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centre, location VUMC, Amsterdam, the Netherlands.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.; de Leng WWJ; Department of Pathology, University Medical Cancer Centre Utrecht, Utrecht, the Netherlands.; Jansen AML; Department of Pathology, University Medical Cancer Centre Utrecht, Utrecht, the Netherlands.; Opdam FL; Department of Clinical Pharmacology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; de Jonge MJA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Cirkel GA; Department of Medical Oncology, Meander, Amersfoort, the Netherlands.; Labots M; Department of Medical Oncology, Amsterdam University Medical Centre, location VUMC, Amsterdam, the Netherlands.; Hoeben A; Department of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Kerver ED; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.; Bins AD; Department of Medical Oncology, Amsterdam University Medical Centre, location AUMC, Amsterdam, the Netherlands.; Erdkamp FGL; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geelen, the Netherlands.; van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen, the Netherlands.; Houtsma D; Department of Medical Oncology, Haga Hospital, The Hague, the Netherlands.; Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.; de Groot JB; Department of Medical Oncology, Isala, Zwolle, the Netherlands.; Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. e.voest@nki.nl.; Oncode Institute, Utrecht, the Netherlands. e.voest@nki.nl.
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Mendelaar PAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; van Riet J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Cancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Angus L; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Labots M; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Steeghs N; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Hendriks MP; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands.; Cirkel GA; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.; van Rooijen JM; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Martini Hospital, Groningen, The Netherlands.; Ten Tije AJ; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands.; Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Cuppen E; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. s.wilting@erasmusmc.nl.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Mendelaar PAJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Smid M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; van Riet J; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Cancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Angus L; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Labots M; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Steeghs N; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Hendriks MP; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Northwest Clinics, Alkmaar, The Netherlands.; Cirkel GA; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.; van Rooijen JM; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Martini Hospital, Groningen, The Netherlands.; Ten Tije AJ; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands.; Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Cuppen E; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Martens JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Wilting SM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. s.wilting@erasmusmc.nl.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; van de Geer WS; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Internal Postal Address NA-1218, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; van Leenders GJLH; Department of Pathology, Erasmus MC, Rotterdam, The Netherlands.; Hamberg P; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.; Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.; Beeker A; Department of Internal Medicine, Spaarne Gasthuis, Hoofddorp, The Netherlands.; Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; van Rooijen JM; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.; Beerepoot LV; Department of Internal Medicine, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands.; Labots M; Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.; Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; Cuppen E; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.; Center for Personalized Cancer Treatment, Rotterdam, The Netherlands.; van de Werken HJG; Cancer Computational Biology Center, Erasmus MC Cancer Institute, University Medical Center, Internal Postal Address NA-1218, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. h.vandewerken@erasmusmc.nl.; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. h.vandewerken@erasmusmc.nl.; Department of Immunology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. h.vandewerken@erasmusmc.nl.; van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands. a.vanderveldt@erasmusmc.nl.; Departments of Radiology & Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands. a.vanderveldt@erasmusmc.nl.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
van Hoeve JC; University of Twente, Health Technology and Services Research, Enschede, the Netherlands; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands. Electronic address: j.vanhoeve@iknl.nl.; Verhoeven RHA; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Nagengast WB; University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.; Oppedijk V; Radiotherapy Institute Friesland, Leeuwarden, the Netherlands.; Lynch MG; Gelre Hospitals, Apeldoorn, the Netherlands.; van Rooijen JM; Martini Hospital, Groningen, the Netherlands.; Veldhuis P; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Siesling S; University of Twente, Health Technology and Services Research, Enschede, the Netherlands; Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Kouwenhoven EA; Hospital Group Twente, Almelo, the Netherlands.
Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE
Academic Journal
Kwakman JJM; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Room F4-224, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. j.j.kwakman@amc.uva.nl.; Academic Medical Center, University of Amsterdam, P.O. Box 22660, 1100 DD, Amsterdam, The Netherlands. j.j.kwakman@amc.uva.nl.; Vink G; Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.; Vestjens JH; Department of Internal Medicine, Viecuri Hospital, Tegelseweg 210, 5912 BL, Venlo, The Netherlands.; Beerepoot LV; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, Doctor Deelenlaan 5, 5042 AD, Tilburg, The Netherlands.; de Groot JW; Department of Medical Oncology, Isala Clinics, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands.; Jansen RL; Department of Medical Oncology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.; Opdam FL; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Boot H; Department of Gastroenterology and Hepatology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Creemers GJ; Department of Medical Oncology, Catharina Hospital, Michelangelolaan 2, 5623 EJ, Eindhoven, The Netherlands.; van Rooijen JM; Department of Medical Oncology, Martini Hospital, Van Swietenplein 1, 9728 NT, Groningen, The Netherlands.; Los M; Department of Medical Oncology, St. Antonius Hospital, Koekoekslaan 1, 3435 CM, Nieuwegein, The Netherlands.; Vulink AJE; Department of Medical Oncology, Reinier de Graaf Gasthuis, Reinier de Graafweg 5, 2625 AD, Delft, The Netherlands.; Schut H; Department of Medical Oncology, Jeroen Bosch Hospital, Henri Dunantstraat 1, 5223 GZ, Den Bosch, The Netherlands.; van Meerten E; Department of Medical Oncology, Erasmus Medical Center, Erasmus University, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.; Baars A; Department of Medical Oncology, Hospital Gelderse Vallei Ede, Willy Brandtlaan 10, 6716 RP, Ede, The Netherlands.; Hamberg P; Department of Medical Oncology, Franciscus Gasthuis, Kleiweg 500, 3045 PM, Rotterdam, The Netherlands.; Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.; Sommeijer DW; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Room F4-224, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; Department of Medical Oncology, Flevo Hospital, Hospitaalweg 1, 1315 RA, Almere, The Netherlands.; Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Room F4-224, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.; Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Academic Journal
de Groot I; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.; Brinkman I; Department of Hospital Pharmacy, Martini Hospital, Groningen, The Netherlands.; Luijendijk-de Bruin D; Department of Urology, Martini Hospital, Groningen, The Netherlands.; Poort S; Department of Nuclear Medicine and Molecular Imaging, Martini Hospital, Groningen, The Netherlands.; van Rooijen JM; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101771568 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1683 (Electronic) Linking ISSN: 26661683 NLM ISO Abbreviation: Eur Urol Open Sci Subsets: PubMed not MEDLINE
Academic Journal
Report
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Report
Kwakman JJM; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: j.j.kwakman@amc.uva.nl.; van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.; Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Eindhoven, the Netherlands.; van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen, the Netherlands.; van de Wouw YAJ; Department of Medical Oncology, VieCuri Medical Center, Venlo, the Netherlands.; Tije AJT; Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands.; Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.; Los M; Department of Medical Oncology, Sint Antonius Hospital, Nieuwegein, the Netherlands.; van Alphen RJ; Department of Medical Oncology, TweeSteden Hospital, Tilburg, the Netherlands.; Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.; Muller EW; Department of Medical Oncology, Slingeland Hospital, Doetinchem, the Netherlands.; van der Velden AMT; Department of Medical Oncology, Tergooi Hospital, Hilversum, the Netherlands.; van Voorthuizen T; Department of Medical Oncology, Rijnstate Hospital, Arnhem, the Netherlands.; Koopman M; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands.; Mol L; Clinical Trial Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen, the Netherlands.; Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Publisher: Elsevier Country of Publication: United States NLM ID: 101120693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0674 (Electronic) Linking ISSN: 15330028 NLM ISO Abbreviation: Clin Colorectal Cancer Subsets: MEDLINE
Academic Journal
Kleinjan JP; Departments of Internal Medicine.; Brinkman I; Hospital Pharmacy.; Bakema R; University of Groningen, Groningen, The Netherlands.; van Zanden JJ; Clinical Chemistry, Certe, Martini Hospital.; van Rooijen JM; Departments of Internal Medicine.
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE
Academic Journal
van Rooijen JM; Department of Internal Medicine, Martini Hospital Groningen, Van Swietenplein 1, 9728NT, Groningen, The Netherlands; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.; Qiu SQ; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands; The Breast Center, Cancer Hospital of Shantou University Medical College, Guangdong, China.; Timmer-Bosscha H; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.; van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.; Boers JE; Department of Pathology, Isala Clinics, Dokter van Heesweg 2 8025 AB, Zwolle, The Netherlands.; Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands.; de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713GZ, Groningen, The Netherlands. Electronic address: e.g.e.de.vries@umcg.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Kwakman JJM; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam.; Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Eindhoven.; van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen.; van de Wouw AJ; Department of Medical Oncology, VieCuri Medical Center, Venlo.; Ten Tije AJ; Department of Medical Oncology, Amphia Hospital, Breda.; Creemers GJM; Department of Medical Oncology, Catharina Hospital, Eindhoven.; Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar.; Los M; Department of Medical Oncology, Sint Antonius Hospital, Nieuwegein.; van Alphen RJ; Department of Medical Oncology, TweeSteden Hospital, Tilburg.; Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden.; Muller EW; Department of Medical Oncology, Slingeland Hospital, Doetinchem.; van der Velden AMT; Department of Medical Oncology, Tergooi Hospital, Hilversum.; van Voorthuizen T; Department of Medical Oncology, Rijnstate Hospital, Arnhem.; Koopman M; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht.; Mol L; Clinical Trial Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen.; van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.; Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
Academic Journal
van Rooijen JM; aDepartment of Internal Medicine, Martini Hospital bDepartment of Medical Oncology, University Medical Center Groningen cDepartment of Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen dDepartment of Research, Netherlands Comprehensive Cancer Organisation, Utrecht eDepartment of Medical Oncology fDepartment of Pathology, Isala, Zwolle gDepartment of Clinical Pharmacy, Deventer Hospital, Deventer hDepartment of Health Technology and Services Research, MIRA Institute, University of Twente, Enschede, The Netherlands.; de Munck L; Teeuwen GM; de Graaf JC; Jansman FG; Boers JE; Siesling S
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE
Academic Journal
van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen, The Netherlands; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands; University of Groningen, Groningen, The Netherlands.; Stutvoet TS; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands; University of Groningen, Groningen, The Netherlands.; Schröder CP; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands; University of Groningen, Groningen, The Netherlands.; de Vries EG; Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands; University of Groningen, Groningen, The Netherlands.
Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther Subsets: MEDLINE
Academic Journal
Kroes R; Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands.; Oosterhof-Berktas R; van Rooijen JM
Publisher: Van Zuiden Communications Country of Publication: Netherlands NLM ID: 0356133 Publication Model: Print Cited Medium: Internet ISSN: 1872-9061 (Electronic) Linking ISSN: 03002977 NLM ISO Abbreviation: Neth J Med Subsets: MEDLINE
Academic Journal
Bensch F; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: f.bensch@umcg.nl.; van Rooijen JM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands.; Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Reyners AK; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE
Academic Journal
van Rooijen JM; Department of Internal Medicine, Martini Hospital, Groningen, The Netherlands. Electronic address: j.vanrooijen@mzh.nl.; de Munck L; Department of Research, Comprehensive Cancer Centre the Netherlands, Utrecht, The Netherlands.; de Graaf JC; Department of Internal Medicine, Isala Klinieken Zwolle, Zwolle, The Netherlands.; Siesling S; Department of Research, Comprehensive Cancer Centre the Netherlands, Utrecht, The Netherlands; MIRA Institute, Health Technology and Services Research, University of Twente, Enschede, The Netherlands.; de Vries EG; Department of Medical Oncology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.; Boers JE; Department of Pathology, Isala Klinieken Zwolle, Zwolle, The Netherlands.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
van Rooijen JM; Departments of Internal Medicine;; Mijnhout GS; Departments of Internal Medicine;; Aalders TT; Neurosurgery;; de Bondt RB; Radiology, Isala Clinics, Zwolle, the Netherlands.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101563282 Publication Model: eCollection Cited Medium: Print ISSN: 2039-7275 (Print) Linking ISSN: 20397275 NLM ISO Abbreviation: Clin Pract Subsets: PubMed not MEDLINE
Academic Journal
van Rooijen JM; Department of Internal Medicine, Isala Clinics Zwolle, the Netherlands. j.m.van.rooijen@isala.nl; Brokkaar L; van Hasselt BA; Groeneveld PH
Publisher: Van Zuiden Communications Country of Publication: Netherlands NLM ID: 0356133 Publication Model: Print Cited Medium: Internet ISSN: 1872-9061 (Electronic) Linking ISSN: 03002977 NLM ISO Abbreviation: Neth J Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] van Rooijen JM
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어